2021 / 04

Next Paper
DOI: 10.24075/medet.2021.032
Copyright: © 2021 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

REVIEW

Ethical aspects of clinical trials of blood clotting factors in children with hemophilia

Kudlay DA1,2, Vdovin VV4, Shiller EE5, Khokholov AL6, Davydkin IL7, Borozinets AYu3
About authors

1 I.M. Sechenov First Moscow State Medical University (Sechenov University), Russia, Moscow

2 NRC Institute of Immunology FMBA of Russia

3 AO “GENERIUM”, Russia, Vladimir region, Volginsky

4 Morozovskaya Children’s City Clinical Hospital, Russia, Moscow

5 Odintsovo Regional Hospital of the Moscow region, Russia, Odintsovo

6 Yaroslavl State Medical University, Yaroslavl, Russia

7 Samara State Medical University, Samara, Russia

Correspondence should be addressed: Anton Yu. Borozinets
ul. Testovskaya, d.10, pod. 2, Moscow, 123112, Russia; ur.muireneg@stenizorob.a

About paper

Authors contribution: Kudlay DA — article design development, analysis of scientific material, review of publications on the topic of the article, article editing; Vdovin VV — literary editing of the article, scientific editing of the article; Schiller EE — analysis of scientific material, review of publications on the topic of the article, editing of the article; Khokhlov AL — literary editing; scientific editing of the article; Davydkin IL — literary editing, scientific editing of the article, summary writing; Borozinets AYu — development of article design, analysis of scientific material, review of publications on the topic of the article, compilation of a summary, writing the text of the article, preparation of a list of references.

Received: 2021-10-08 Accepted: 2021-11-24 Published online: 2021-12-30
|
Figure. Sequence of clinical trials of new medicinal preparations of blood coagulation factor FVIII in different age groups [16]